1 | Abatacept (ABA) + Methotrexate (MTX), double-blind (DB) (Synonym: Otrexup (TN)) | [2] Abatacept Abatacept, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D03203
| [4] CD80 CD80, CD86, DHFR, DHFR2 💬 | [17] Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
2 | Abatacept + Methotrexate (Synonym: Otrexup (TN)) | [2] Abatacept Abatacept, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D03203
| [4] CD80 CD80, CD86, DHFR, DHFR2 💬 | [17] Allograft rejection Allograft rejection, Antifolate resistance, Autoimmune thyroid disease, Biosynthesis of cofactors, Cell adhesion molecules, Folate biosynthesis, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Metabolic pathways, One carbon pool by folate, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 46 46 |
3 | Adalimumab 40 mg sc every other week | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 271 271 |
4 | Adalimumab 40 mg subcutaneous (SC) every other week (EOW) | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
5 | Adalimumab with methotrexate (Synonym: Otrexup (TN)) | [2] Adalimumab Adalimumab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02597
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
6 | Any other approved Antiepileptic Drug | - | - | - | - | [1] 144 144 |
7 | Apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side | [1] Sinecatechins Sinecatechins | [1] D08997
D08997
| - | - | [1] 160 160 |
8 | Apremilast (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [7] 46 46, 50, 56, 97, 107, 162, 271 |
9 | Apremilast (CC-10004) (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 56 56 |
10 | Apremilast 10 mg (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 |
11 | Apremilast 20 mg (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 |
12 | Apremilast 30 mg (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 46 46, 56, 107 |
13 | Apremilast 30mg (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 50 50 |
14 | Apremilast tablet 20 mg (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 |
15 | Apremilast tablet 30 mg BID (Synonym: Otezla (TN)) | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 271 271 |
16 | AZATHIOPRINE or METHOTREXATE (Synonym: Otrexup (TN)) | [2] Azathioprine Azathioprine, Methotrexate (Synonym: Otrexup) | [4] D00142
D00142
(Name: Otrexup (TN)),
D00238
,
D02115
,
D03033
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
17 | Behavioral: Other Academic sham tutoring | - | - | - | - | [1] 34 34 |
18 | BMN 110 - Every Other Week | - | - | - | - | [1] 19 19 |
19 | BMN 110 Every Other Week | - | - | - | - | [1] 19 19 |
20 | BMS Drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) (Synonym: Prilosec OTC (TN)) | [5] Digoxin Digoxin, Flurbiprofen, Midazolam, Montelukast, Omeprazole (Synonym: Prilosec OTC) | [13] D00298
D00298
,
D00330
,
D00455
,
D00529
,
D00550
,
D00696
,
D01207
,
D01475
,
D02290
,
D05028
,
D05259
(Name: Prilosec OTC (TN)),
D05261
,
D08229
| [25] ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP4A, ATP4B, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, PTGS1, PTGS2 💬 | [49] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
21 | BMS-582949 and Methotrexate (Synonym: Otrexup (TN)) | [2] BMS-582949 BMS-582949, Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
22 | Bromocriptine and other dopamine agonists | [2] Bromocriptine Bromocriptine, Dopamine | [4] D00633
D00633
,
D00780
,
D03165
,
D07870
| [6] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 | [15] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
23 | Busulfan/Fludarabine phosphate/Tacrolimus/Methotrexate/G-CSF (Synonym: Otrexup (TN)) | [6] Busulfan Busulfan, Filgrastim, Fludarabine, Methotrexate (Synonym: Otrexup), Phosphate ion, Tacrolimus | [8] D00107
D00107
,
D00142
(Name: Otrexup (TN)),
D00248
,
D01907
,
D02115
,
D03235
,
D07966
,
D08556
| [9] CSF3R CSF3R, DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 | [47] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Drug metabolism - other enzymes, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
24 | Certolizumab Pegol + Methotrexate (MTX) (Synonym: Otrexup (TN)) | [2] Certolizumab pegol Certolizumab pegol, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D03441
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
25 | Cipro (Ciprofloxacin, BAYQ3939) (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
26 | Ciprofloxacin (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [5] 2 2, 60, 96, 97, 299 |
27 | Ciprofloxacin (BAYQ3939) dry powder for inhalation (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
28 | Ciprofloxacin (Cipro Inhale, BAYQ3939) (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
29 | Ciprofloxacin (Cipro, BAYQ3939) (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
30 | Ciprofloxacin (ciproxin) (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
31 | Ciprofloxacin dispersion for inhalation (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
32 | Ciprofloxacin DPI (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
33 | Ciprofloxacin DPI (BAYQ3939) (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
34 | Ciprofloxacin for Inhalation (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
35 | Ciprofloxacin hydrochloride (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [2] 96 96, 299 |
36 | CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
37 | Ciprofloxacin Inhale (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
38 | Clartihromycin, amoxicillin, and omeprazole (Synonym: Prilosec OTC (TN)) | [2] Amoxicillin Amoxicillin, Omeprazole (Synonym: Prilosec OTC) | [7] D00229
D00229
,
D00455
,
D01207
,
D02925
,
D05259
(Name: Prilosec OTC (TN)),
D05261
,
D07452
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 6 6 |
39 | Clobetasol propionate + Methotrexate (Synonym: Otrexup (TN)) | [3] Clobetasol Clobetasol, Clobetasol propionate, Methotrexate (Synonym: Otrexup) | [4] D00142
D00142
(Name: Otrexup (TN)),
D01272
,
D02115
,
D07715
| [3] DHFR DHFR, DHFR2, NR3C1 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 162 162 |
40 | Combination Product: Exercise, and methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
41 | Combination Product: Laser, exercise, and methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
42 | Combination Product: Methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
43 | CP-690,550 + methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
44 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids (Synonym: Otrexup (TN)) | [3] Azathioprine Azathioprine, Cyclophosphamide, Methotrexate (Synonym: Otrexup) | [6] D00142
D00142
(Name: Otrexup (TN)),
D00238
,
D00287
,
D02115
,
D03033
,
D07760
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
45 | Cyclosporin, Methotrexate (GVHD prophylaxis) (Synonym: Otrexup (TN)) | [2] Cyclosporine Cyclosporine, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D00184
,
D02115
| [7] DHFR DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [38] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 326 326 |
46 | Diagnostic Test: Other exploratory blood biomarkers | - | - | - | - | [1] 298 298 |
47 | Diclofenac + Omeprazole (Synonym: Prilosec OTC (TN)) | [2] Diclofenac Diclofenac, Omeprazole (Synonym: Prilosec OTC) | [7] D00455
D00455
,
D00903
,
D00904
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
,
D07816
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
48 | Dimebon + Omeprazole (Synonym: Prilosec OTC (TN)) | [2] Latrepirdine Latrepirdine, Omeprazole (Synonym: Prilosec OTC) | [5] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
,
D09917
| [8] ACHE ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [26] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 8 8 |
49 | DMARDs (methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
50 | Doxorubicin, methotrexate, cyclophosphamide, L-asparaginase (Synonym: Otrexup (TN)) | [4] Asparaginase Escherichia coli Asparaginase Escherichia coli, Cyclophosphamide, Doxorubicin, Methotrexate (Synonym: Otrexup) | [6] D00142
D00142
(Name: Otrexup (TN)),
D00287
,
D02115
,
D02997
,
D03899
,
D07760
| [4] DHFR DHFR, DHFR2, TOP2A, TOP2B 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Platinum drug resistance 💬 | [1] 65 65 |
51 | Early immunosuppressants (azathioprine, methotrexate) (Synonym: Otrexup (TN)) | [2] Azathioprine Azathioprine, Methotrexate (Synonym: Otrexup) | [4] D00142
D00142
(Name: Otrexup (TN)),
D00238
,
D02115
,
D03033
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
52 | Enalapril and other angiotensin converting enzyme inhibitors | [2] Angiotensin II Angiotensin II, Enalapril | [4] D00150
D00150
,
D00621
,
D02014
,
D07892
| [3] ACE ACE, AGTR1, AGTR2 💬 | [18] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 |
53 | Etanercept + Methotrexate (Synonym: Otrexup (TN)) | [2] Etanercept Etanercept, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D00742
,
D02115
| [4] DHFR DHFR, DHFR2, LTA, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
54 | Etanercept , Methotrexate (Synonym: Otrexup (TN)) | [2] Etanercept Etanercept, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D00742
,
D02115
| [4] DHFR DHFR, DHFR2, LTA, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
55 | Etanercept, methotrexate and depomedrone (Synonym: Otrexup (TN)) | [2] Etanercept Etanercept, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D00742
,
D02115
| [4] DHFR DHFR, DHFR2, LTA, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
56 | Etanercept, Methotrexate, Prednisolone (Synonym: Otrexup (TN)) | [3] Etanercept Etanercept, Methotrexate (Synonym: Otrexup), Prednisolone | [11] D00142
D00142
(Name: Otrexup (TN)),
D00472
,
D00742
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02115
,
D02156
,
D03301
| [5] DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | [72] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 56 56 |
57 | Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
58 | Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below) | - | - | - | - | [1] 6 6 |
59 | Ezetimibe + other lipid-lowering medication(s) | [1] Ezetimibe Ezetimibe | [1] D01966
D01966
| [1] NPC1L1 NPC1L1 💬 | [1] Fat digestion and absorption Fat digestion and absorption 💬 | [1] 260 260 |
60 | Fixed dose combination Ciprofloxacin/Celecoxib (Synonym: CIPROFLOXACIN OTIC) | [2] Celecoxib Celecoxib, Ciprofloxacin (Synonym: Otovel) | [3] D00186
D00186
(Name: Otiprio (TN)),
D00567
,
D02216
(Name: CIPROFLOXACIN OTIC) | [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 2 2 |
61 | Fluocinolone Acetonide (Synonym: FLAC OTIC OIL) | [2] Fluocinolone Fluocinolone, Fluocinolone acetonide (Synonym: Synalar Bi-otic Solution) | [1] D01825
D01825
(Name: FLAC OTIC OIL) | [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 90 90 |
62 | Genetic: Infusion of autologous cryopreserved EFS-ADA LV CD34+ cells (OTL-101) | - | - | - | - | [1] 65 65 |
63 | Genetic: Infusion of autologous EFS-ADA LV CD34+ (OTL-101) | - | - | - | - | [1] 65 65 |
64 | GSK3196165 (Otilimab) | [1] Otilimab Otilimab | [1] D11343
D11343
(Name: Otilimab) | [1] CSF2 CSF2 💬 | [16] Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [2] 46 46, 256 |
65 | Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate) (Synonym: Otrexup (TN)) | [4] Azathioprine Azathioprine, Methotrexate (Synonym: Otrexup), Mycophenolate mofetil, Mycophenolic acid | [8] D00142
D00142
(Name: Otrexup (TN)),
D00238
,
D00752
,
D02115
,
D03033
,
D05094
,
D05095
,
D05096
| [4] DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | [7] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism 💬 | [1] 49 49 |
66 | Immunosuppressors (Thiopurines or Methotrexate) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
67 | Infliximab + methotrexate (MTX) (Synonym: Otrexup (TN)) | [2] Infliximab Infliximab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02598
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
68 | Infliximab plus methotrexate (Synonym: Otrexup (TN)) | [2] Infliximab Infliximab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02598
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 107 107 |
69 | Infliximab, methylprednisolone, methotrexate (Synonym: Otrexup (TN)) | [3] Infliximab Infliximab, Methotrexate (Synonym: Otrexup), Methylprednisolone | [9] D00142
D00142
(Name: Otrexup (TN)),
D00407
,
D00751
,
D00979
,
D02115
,
D02598
,
D05000
,
D05001
,
D05002
| [4] DHFR DHFR, DHFR2, NR3C1, TNF 💬 | [72] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
70 | Intrathecal methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 13 13 |
71 | L01X - Other antineoplastic agents | - | - | - | - | [1] 85 85 |
72 | Losartan and other angiotensin receptor blockers | [2] Angiotensin II Angiotensin II, Losartan | [4] D00150
D00150
,
D00357
,
D02014
,
D08146
| [2] AGTR1 AGTR1, AGTR2 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 19 19 |
73 | M2951 (Other Name: Evobrutinib) | [1] Evobrutinib Evobrutinib | - | - | - | [1] 49 49 |
74 | Methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [38] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
75 | Methotrexate 'Lederle' 2,5mg tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
76 | Methotrexate 'Lederle' 2.5mg Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
77 | Methotrexate 'Lederle' Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
78 | Methotrexate (Metoject® prefilled pen) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
79 | Methotrexate (MTX) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
80 | Methotrexate (stable dose) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
81 | Methotrexate (tapering dose) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
82 | Methotrexate + biologic administration (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
83 | Methotrexate + Infliximab (Synonym: Otrexup (TN)) | [2] Infliximab Infliximab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02598
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
84 | Methotrexate + Methylprednisolone (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Methylprednisolone | [8] D00142
D00142
(Name: Otrexup (TN)),
D00407
,
D00751
,
D00979
,
D02115
,
D05000
,
D05001
,
D05002
| [3] DHFR DHFR, DHFR2, NR3C1 💬 | [6] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | [1] 46 46 |
85 | Methotrexate + salazopyrine + hydroxychloroquine administration (Synonym: Otrexup (TN)) | [2] Hydroxychloroquine Hydroxychloroquine, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D08050
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
86 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 96 96 |
87 | Methotrexate - Amneal (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
88 | Methotrexate - DAVA (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
89 | Methotrexate - Delay (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
90 | Methotrexate - etanercept - prednisolone arm (Synonym: Otrexup (TN)) | [3] Etanercept Etanercept, Methotrexate (Synonym: Otrexup), Prednisolone | [11] D00142
D00142
(Name: Otrexup (TN)),
D00472
,
D00742
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02115
,
D02156
,
D03301
| [5] DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | [72] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 46 46, 107 |
91 | Methotrexate - Immediate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
92 | Methotrexate 10 mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
93 | Methotrexate 10 mg tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
94 | Methotrexate 2.5 mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
95 | METHOTREXATE 2.5 mg tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
96 | Methotrexate 2.5mg Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
97 | Methotrexate 2.5mg Tablets BP (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
98 | Methotrexate 25 mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 |
99 | Methotrexate 50mg/ml solution for injection, pre-filled syringe (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
100 | Methotrexate ``Lederle`` 2.5mg tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
101 | Methotrexate alone (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 107 107 |
102 | Methotrexate and folic acid (Synonym: Otrexup (TN)) | [2] Folic acid Folic acid, Methotrexate (Synonym: Otrexup) | [3] D00070
D00070
,
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 49 49 |
103 | Methotrexate as methotrexate disodium (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
104 | Methotrexate bellon (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 97 97 |
105 | Methotrexate bellon 25mg/ml (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 97 97 |
106 | Methotrexate capsules (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
107 | METHOTREXATE DISODIUM (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [5] 46 46, 96, 97, 107, 271 |
108 | Methotrexate Ebewe (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
109 | METHOTREXATE HOSPIRA 2,5 mg tablety (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
110 | METHOTREXATE HOSPIRA 2.5 mg tablety (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
111 | Methotrexate injection (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 96 96, 97 |
112 | Methotrexate Lachema 5inj. sol (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 50 50 |
113 | Methotrexate Lederle 2.5 mg Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
114 | Methotrexate Pfizer 2,5 mg tabletter (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
115 | Methotrexate Placebo (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
116 | Methotrexate plus ENBREL or ENBREL alone (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
117 | Methotrexate plus ERB-041 for 12 weeks (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
118 | Methotrexate plus sulfasalazine (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Sulfasalazine | [3] D00142
D00142
(Name: Otrexup (TN)),
D00448
,
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
119 | Methotrexate pre-filled pen (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
120 | Methotrexate prefilled pen (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 46 46, 107 |
121 | Methotrexate prefilled syringe (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
122 | METHOTREXATE SODIUM (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 46 46, 256 |
123 | Methotrexate Sodium 2.5mg Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
124 | Methotrexate Sodium Tablets 2.5 mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
125 | Methotrexate Sodium Tablets 2.5mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
126 | Methotrexate Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 40 40 |
127 | Methotrexate tablets 2.5 mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
128 | Methotrexate treatment (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 41 41, 46 |
129 | Methotrexate Wyeth 2,5mg (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 50 50 |
130 | Methotrexate Wyeth 2,5mg tbl. (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 50 50 |
131 | Methotrexate ® 2.5mg Tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
132 | Methotrexate(MTX) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
133 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
134 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
135 | Methotrexate(necessary) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
136 | METHOTREXATE*100CPR 2,5MG (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
137 | METHOTREXATE*10MG/1,33ML 4S (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
138 | METHOTREXATE*15MG/2ML 4SIR (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
139 | METHOTREXATE*2,5MG 25CPR (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
140 | METHOTREXATE*20MG/2,66ML 4S (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
141 | METHOTREXATE*25CPR 2,5MG (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [2] 46 46, 107 |
142 | METHOTREXATE*7,5MG/ML 4SIR. (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
143 | Methotrexate, Leucovorin and BMS-986142 (Synonym: Otrexup (TN)) | [3] BMS-986142 BMS-986142, Leucovorin, Methotrexate (Synonym: Otrexup) | [5] D00142
D00142
(Name: Otrexup (TN)),
D01211
,
D02115
,
D07986
,
D07987
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
144 | Methotrexate,Adalimumab (Synonym: Otrexup (TN)) | [2] Adalimumab Adalimumab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02597
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
145 | Methotrexate-Lachema (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
146 | Methotrexate-Sulfasalazine-Hydroxychloroquine (Synonym: Otrexup (TN)) | [3] Hydroxychloroquine Hydroxychloroquine, Methotrexate (Synonym: Otrexup), Sulfasalazine | [4] D00142
D00142
(Name: Otrexup (TN)),
D00448
,
D02115
,
D08050
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
147 | Methotrexate® 2.5 mg tablets (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
148 | Methylprednisolone (or other glucocorticoid) | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 |
149 | MP-435(dose1) + Methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
150 | MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046) | [2] Human interferon beta Human interferon beta, Interferon beta-1b | [1] D00746
D00746
| [2] IFNAR1 IFNAR1, IFNAR2 💬 | [18] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [1] 13 13 |
151 | Mycophenolate mofetil,methotrexate (Synonym: Otrexup (TN)) | [3] Methotrexate Methotrexate (Synonym: Otrexup), Mycophenolate mofetil, Mycophenolic acid | [6] D00142
D00142
(Name: Otrexup (TN)),
D00752
,
D02115
,
D05094
,
D05095
,
D05096
| [4] DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | [7] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism 💬 | [3] 42 42, 43, 45 |
152 | Naproxen 500 mg tablets (PN 200 minus omeprazole) (Synonym: Prilosec OTC (TN)) | [2] Naproxen Naproxen, Omeprazole (Synonym: Prilosec OTC) | [5] D00118
D00118
,
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
153 | Omeprazole (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
154 | Omeprazole (UK licensed generic product) (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 85 85 |
155 | Omeprazole 20 mg (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2] 96 96, 97 |
156 | Omeprazole 20 MG Oral Tablet (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 98 98 |
157 | Omeprazole 20mg (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 51 51 |
158 | Omeprazole 20mg BID (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 98 98 |
159 | Omeprazole 40 mg (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 96 96 |
160 | Omeprazole 40mg Capsule (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 299 299 |
161 | OMEPRAZOLE MAGNESIUM (Synonym: Prilosec OTC (TN)) | [2] Magnesium Magnesium, Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 225 225 |
162 | Omeprazole rectally 1mg/kg (Synonym: Prilosec OTC (TN)) | [1] Omeprazole Omeprazole (Synonym: Prilosec OTC) | [4] D00455
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 294 294 |
163 | Oral ciprofloxacin (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
164 | Oral ciprofloxacin plus inhaled colistin (Synonym: CIPROFLOXACIN OTIC) | [2] Ciprofloxacin Ciprofloxacin (Synonym: Otovel), Colistin | [4] D00186
D00186
(Name: Otiprio (TN)),
D02138
,
D02216
(Name: CIPROFLOXACIN OTIC),
D07746
| - | - | [1] 299 299 |
165 | Oral methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
166 | OT | - | - | - | - | [1] 193 193 |
167 | Otelixizumab | [1] Otelixizumab Otelixizumab | [1] D08959
D08959
(Name: Otelixizumab) | [3] CD3D CD3D, CD3E, CD3G 💬 | [11] Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 46 46 |
168 | Otezla | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 56 56, 107, 162 |
169 | OTEZLA - 10 MG + 20 MG + 30 MG COMPRESSA RIVESTITA CON FILM USO ORALE - BLISTER (PVC/ALU) IN UN ASTUCCIO - 4 COMPRESSE DA 10 MG + 4 COMPRESSE DA 20 MG +19 COMPRESSE DA 30 MG | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [2] 56 56, 107 |
170 | OTEZLA - 30 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PVC/ALU) - 56 COMPRESSE | [1] Apremilast Apremilast (Synonym: Otezla) | [1] D08860
D08860
(Name: Otezla (TN)) | [4] PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | [5] Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 107 107 |
171 | Other analgesics and antipyretics | - | - | - | - | [1] 13 13 |
172 | Other antiepileptics | - | - | - | - | [1] 140 140 |
173 | Other Biologic Therapies | - | - | - | - | [2] 96 96, 97 |
174 | Other biological agent | - | - | - | - | [2] 46 46, 96 |
175 | Other Biologics | - | - | - | - | [1] 46 46 |
176 | Other COX-2 inhibitor | - | - | - | - | [1] 271 271 |
177 | Other Cox-2 inhibitors | - | - | - | - | [1] 271 271 |
178 | Other Crystalloid | - | - | - | - | [1] 296 296 |
179 | Other disease-modifying therapy | - | - | - | - | [1] 13 13 |
180 | Other DMARDs | - | - | - | - | [1] 46 46 |
181 | Other H1 antagonist | - | - | - | - | [1] 13 13 |
182 | Other hematological Agents | - | - | - | - | [1] 65 65 |
183 | Other intervention(s) | - | - | - | - | [1] 70 70 |
184 | OTHER NERVOUS SYSTEM DRUGS | - | - | - | - | [2] 6 6, 13 |
185 | Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac | [1] Etodolac Etodolac | [1] D00315
D00315
| [1] PTGS2 PTGS2 💬 | [22] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
186 | Other Non-selective NSAIDs | - | - | - | - | [1] 271 271 |
187 | Other non-sponsor pancreatic enzyme replacement therapy | - | - | - | - | [1] 299 299 |
188 | Other Parkinson's Disease treatments | - | - | - | - | [1] 6 6 |
189 | Other respiratory system products | - | - | - | - | [1] 299 299 |
190 | OTHER SOURCES | - | - | - | - | [1] 228 228 |
191 | Other vasodilator | - | - | - | - | [1] 51 51 |
192 | Other: | - | - | - | - | [2] 2 2, 65 |
193 | Other: 0 mg | - | - | - | - | [1] 97 97 |
194 | Other: 0.02% Fm, SH, tBCL | - | - | - | - | [1] 53 53 |
195 | Other: 0.9% sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 65 65 |
196 | Other: 0.9ml sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 271 271 |
197 | Other: 1 Food Elimination Diet | - | - | - | - | [1] 98 98 |
198 | Other: 1 Food Elimination Diet Therapy | - | - | - | - | [1] 98 98 |
199 | Other: 100% pomegranate juice | [1] Pomegranate Pomegranate | - | - | - | [2] 96 96, 97 |
200 | Other: 13C6 Leucine | [1] Leucine Leucine | [1] D00030
D00030
| - | - | [3] 5 5, 7, 127 |
201 | Other: 18F-FDG | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [2] 46 46, 84 |
202 | Other: 18F-FDG PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 41 41 |
203 | Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT | [1] Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | [1] 84 84 |
204 | Other: 18F-GE-180 | [1] Flutriciclamide F-18 Flutriciclamide F-18 | - | - | - | [1] 46 46 |
205 | Other: 2h standardized aerobic exercise | - | - | - | - | [1] 78 78 |
206 | Other: 3-days water-fasting | [1] Water Water | [1] D00001
D00001
| - | - | [1] 67 67 |
207 | Other: 31-Phosphorus RMN Spectroscopy | [1] Phosphorus Phosphorus | - | - | - | [1] 8 8 |
208 | Other: 4 Food Elimination Diet | - | - | - | - | [1] 98 98 |
209 | Other: 4 Food Elimination Diet (post 1FED failure) | - | - | - | - | [1] 98 98 |
210 | Other: 5-ASA Withdrawal | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 96 96 |
211 | Other: 6 Food Elimination Diet (after 1FED failure) | - | - | - | - | [1] 98 98 |
212 | Other: 6 Food Elimination Diet Therapy | - | - | - | - | [1] 98 98 |
213 | Other: 60% Oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 85 85 |
214 | Other: [11C]-Methionine PET/MRI | [1] Methionine Methionine | [2] D00019
D00019
,
D04983
| - | - | [1] 75 75 |
215 | Other: [11C]donepezil PET | [1] Donepezil Donepezil | [2] D00670
D00670
,
D07869
| [1] ACHE ACHE 💬 | [2] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | [1] 6 6 |
216 | Other: A-STEP | - | - | - | - | [1] 299 299 |
217 | Other: A-STEP (New Protocol) | - | - | - | - | [1] 299 299 |
218 | Other: Abdominal compression | - | - | - | - | [1] 17 17 |
219 | Other: Absorptive clearance scan | - | - | - | - | [1] 299 299 |
220 | Other: Acute response to high-impact exercise | - | - | - | - | [1] 96 96 |
221 | Other: Ad libitum water intake | [1] Water Water | [1] D00001
D00001
| - | - | [1] 67 67 |
222 | Other: Adalimumab | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
223 | Other: Adalimumab treatment | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 151 151 |
224 | Other: Additional Therapies | - | - | - | - | [1] 97 97 |
225 | Other: Air - oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 299 299 |
226 | Other: Aminoacid, alanine-infusion | [1] Alanine Alanine | [1] D00012
D00012
| - | - | [1] 251 251 |
227 | Other: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised | - | - | - | - | [1] 2 2 |
228 | Other: Antigen (wheat base soy sauce) spray | [1] Wheat Wheat | [1] D06902
D06902
| - | - | [1] 98 98 |
229 | Other: anxiety | - | - | - | - | [1] 13 13 |
230 | Other: Assessment of medication compliance | - | - | - | - | [1] 98 98 |
231 | Other: At-home natalizumab treated MS patient | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
232 | Other: Autogenic drainage | - | - | - | - | [1] 299 299 |
233 | Other: Autologous Platelet rich plasma | - | - | - | - | [1] 35 35 |
234 | Other: autologous serum and rebamipide 2% | [1] Rebamipide Rebamipide | [1] D01121
D01121
| - | - | [1] 53 53 |
235 | Other: Avise PG - Diagnostic test | - | - | - | - | [1] 46 46 |
236 | Other: Balance | [1] Isoxaflutole Isoxaflutole | - | - | - | [3] 6 6, 13, 299 |
237 | Other: Balance exercise | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
238 | Other: Balance exercise program using exoskeleton device | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
239 | Other: Balance exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
240 | Other: Balance Trainer Balance Exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
241 | Other: Balance Training | [1] Isoxaflutole Isoxaflutole | - | - | - | [2] 6 6, 13 |
242 | Other: Baseline serum vitamin D level at or above 50 nmol/l | [1] Vitamin D Vitamin D | - | - | - | [1] 46 46 |
243 | Other: Baseline serum vitamin D level below 50 nmol/l | [1] Vitamin D Vitamin D | - | - | - | [1] 46 46 |
244 | Other: beetroot juice extract | - | - | - | - | [1] 113 113 |
245 | Other: Berg Balance Scale | [1] Isoxaflutole Isoxaflutole | - | - | - | [2] 6 6, 13 |
246 | Other: Best Medical Treatment | - | - | - | - | [1] 6 6 |
247 | Other: Best Practice | - | - | - | - | [1] 60 60 |
248 | Other: Biological samples | - | - | - | - | [1] 206 206 |
249 | Other: Biopsy | - | - | - | - | [1] 51 51 |
250 | Other: Blood analysis for frataxin's level measurement | - | - | - | - | [1] 18 18 |
251 | Other: Blood collection for measurement of eculizumab peak concentrations | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 62 62 |
252 | Other: Blood drawing only Group C | - | - | - | - | [1] 49 49 |
253 | Other: Blood draws | - | - | - | - | [3] 49 49, 51, 85 |
254 | Other: Blood glucose results | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 299 299 |
255 | Other: blood sample | - | - | - | - | [1] 299 299 |
256 | Other: Blood sample and cotton skin swabs | [1] Cotton Cotton | - | - | - | [1] 162 162 |
257 | Other: Blood samples | - | - | - | - | [1] 93 93 |
258 | Other: Blood sampling for Laboratory Developed Test (LDT) analysis | - | - | - | - | [1] 65 65 |
259 | Other: Blood test | - | - | - | - | [2] 83 83, 96 |
260 | Other: Blood-flow restricted training | - | - | - | - | [1] 15 15 |
261 | Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study. | - | - | - | - | [1] 230 230 |
262 | Other: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study. | - | - | - | - | [1] 230 230 |
263 | Other: Bone Marrow aspiration | - | - | - | - | [1] 2 2 |
264 | Other: Bone Marrow Cell Transplantation | - | - | - | - | [1] 274 274 |
265 | Other: Brain MRI (magnetic resonance imaging) | - | - | - | - | [1] 17 17 |
266 | Other: Brief Pain Inventory questionnaire | - | - | - | - | [1] 19 19 |
267 | Other: Bronchoalveolar samples | - | - | - | - | [1] 51 51 |
268 | Other: BSC | - | - | - | - | [1] 85 85 |
269 | Other: Caffeine | [1] Caffeine Caffeine | [2] D00528
D00528
,
D01453
| [11] ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | [22] Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
270 | Other: Calcium stable isotope | [1] Calcium Calcium | - | - | - | [1] 186 186 |
271 | Other: Carbon monoxide-bubbled mediums | [2] Activated charcoal Activated charcoal, Carbon monoxide | [1] D09706
D09706
| - | - | [1] 298 298 |
272 | Other: carboxy methyl cellulose | [2] Methylcellulose Methylcellulose, Microcrystalline cellulose | [2] D00093
D00093
,
D04996
| - | - | [1] 53 53 |
273 | Other: Cardiopulmonary evaluation | - | - | - | - | [1] 13 13 |
274 | Other: Cawthorne Cooksey exercises | - | - | - | - | [1] 13 13 |
275 | Other: CD LFD | - | - | - | - | [1] 96 96 |
276 | Other: CD-TREAT diet | - | - | - | - | [1] 96 96 |
277 | Other: Challenge agent: capsaicin | [1] Capsaicin Capsaicin (Synonym: Pallerix OTC BIOfrequency Chip) | [1] D00250
D00250
| [1] TRPV1 TRPV1 💬 | [2] Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 19 19 |
278 | Other: Classic, progressive endurance training | - | - | - | - | [1] 13 13 |
279 | Other: Clinical data collection | - | - | - | - | [3] 49 49, 51, 85 |
280 | Other: clinical observation | - | - | - | - | [1] 205 205 |
281 | Other: CoA-Z | - | - | - | - | [1] 120 120 |
282 | Other: Coaching Sessions | - | - | - | - | [1] 49 49 |
283 | Other: CoDuSe balance training and step square exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
284 | Other: Coffee | [1] Arabica coffee bean Arabica coffee bean | - | - | - | [1] 96 96 |
285 | Other: Cognitive training | - | - | - | - | [1] 206 206 |
286 | Other: Colchicine Cessation | [1] Colchicine Colchicine | [1] D00570
D00570
| [9] TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | [10] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [1] 266 266 |
287 | Other: collection of CSF, blood, urine, saliva | - | - | - | - | [1] 6 6 |
288 | Other: Communicative Effectiveness Survey | - | - | - | - | [1] 2 2 |
289 | Other: Comparator: CPET cycle ergometer (Gold Standard) | [1] Gold Gold | - | - | - | [1] 299 299 |
290 | Other: Computer game based balance and walking rehabilitation for individuals with Parkinson's Disease | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
291 | Other: Concomitant Medication | - | - | - | - | [1] 49 49 |
292 | Other: Continuation of dornase alfa (dnase) | [1] Dornase alfa Dornase alfa | [1] D03896
D03896
| - | - | [1] 299 299 |
293 | Other: Continuation of hypertonic saline (HS) | - | - | - | - | [1] 299 299 |
294 | Other: continue their usual therapy | - | - | - | - | [1] 66 66 |
295 | Other: Control | - | - | - | - | [9] 6 6, 19, 67, 70, 75, 85, 97, 162, 193 |
296 | Other: Control Diet | - | - | - | - | [1] 96 96 |
297 | Other: Control group | - | - | - | - | [1] 2 2 |
298 | Other: Control group(Normal saline) | - | - | - | - | [1] 97 97 |
299 | Other: Control wound treatment | - | - | - | - | [1] 36 36 |
300 | Other: Controlled environment tests (series of tasks of everyday life) | - | - | - | - | [1] 6 6 |
301 | Other: Controls Primary Cervical Dystonia (Trihexyphenidyl) | [1] Trihexyphenidyl Trihexyphenidyl | [2] D00787
D00787
,
D08638
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 6 6 |
302 | Other: conventional balance training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
303 | Other: Conventional drugs | - | - | - | - | [1] 97 97 |
304 | Other: Conventional PCA mode | - | - | - | - | [1] 70 70 |
305 | Other: Conventional physiotherapy | - | - | - | - | [1] 6 6 |
306 | Other: Core stability | - | - | - | - | [1] 13 13 |
307 | Other: corn starch | [1] Starch, corn Starch, corn | [1] D05297
D05297
| - | - | [1] 49 49 |
308 | Other: corticotropin releasing hormone (CRH) | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 78 78 |
309 | Other: Cough monitor | [1] Methamidophos Methamidophos | - | - | - | [1] 85 85 |
310 | Other: Covid-19 vaccine | - | - | - | - | [1] 13 13 |
311 | Other: Crohn's disease exclusion diet (CDED) | - | - | - | - | [1] 96 96 |
312 | Other: Crohn's Disease TReatment-with-EATing diet (CD-TREAT diet) | - | - | - | - | [1] 96 96 |
313 | Other: Crohns Disease Exclusion Diet | - | - | - | - | [1] 96 96 |
314 | Other: Cultured Thymus Tissue Implantation and Parental Parathyroid Transplantation | - | - | - | - | [1] 65 65 |
315 | Other: Cultured Thymus Tissue Implantation with Parathyroid Transplantation | - | - | - | - | [1] 65 65 |
316 | Other: current treatment | - | - | - | - | [1] 46 46 |
317 | Other: cyclosporin A | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
318 | Other: Cysteamine bitartrate | [1] Cysteamine Cysteamine | [2] D03634
D03634
,
D03635
| - | - | [1] 19 19 |
319 | Other: D-xylose | [1] Xylose Xylose | [1] D06346
D06346
| - | - | [1] 98 98 |
320 | Other: D5W | - | - | - | - | [1] 222 222 |
321 | Other: Data Capture | [1] Bifenthrin Bifenthrin | - | - | - | [1] 6 6 |
322 | Other: De-implementation of Inhaled Nitric Oxide (iNO) use | [1] Nitric Oxide Nitric Oxide | [1] D00074
D00074
| - | - | [1] 294 294 |
323 | Other: Dead Sea Solar and Water Treatment | [1] Water Water | [1] D00001
D00001
| - | - | [1] 46 46 |
324 | Other: Determination of calcium intake by a dietician interview | [1] Calcium Calcium | - | - | - | [2] 13 13, 46 |
325 | Other: dextrose water 5% | [2] Dextrose, unspecified form Dextrose, unspecified form, Water | [1] D00001
D00001
| - | - | [1] 56 56 |
326 | Other: diagnostic laboratory biomarker analysis | - | - | - | - | [1] 74 74 |
327 | Other: Diagnostics for glucose tolerance with 3 different methods. | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 299 299 |
328 | Other: Diary completion | - | - | - | - | [1] 6 6 |
329 | Other: Diet | - | - | - | - | [1] 240 240 |
330 | Other: Diet treatment | - | - | - | - | [1] 240 240 |
331 | Other: Diet-CD | - | - | - | - | [1] 96 96 |
332 | Other: dietary intervention with no-carrageenan diet | - | - | - | - | [1] 97 97 |
333 | Other: Dietary recommendations | - | - | - | - | [1] 51 51 |
334 | Other: Digestible Maltodextrin | [1] Maltodextrin Maltodextrin | [1] D02329
D02329
| - | - | [1] 96 96 |
335 | Other: Discontinuation of dornase alfa (dnase) | [1] Dornase alfa Dornase alfa | [1] D03896
D03896
| - | - | [1] 299 299 |
336 | Other: Discontinuation of hypertonic saline (HS) | - | - | - | - | [1] 299 299 |
337 | Other: DMT withdrawal | - | - | - | - | [1] 13 13 |
338 | Other: dobutamine | [1] Dobutamine Dobutamine | [4] D00632
D00632
,
D03879
,
D03880
,
D03881
| [1] ADRB1 ADRB1 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 215 215 |
339 | Other: Donor derived G-CSF mobilized PBC | [1] Filgrastim Filgrastim | [1] D03235
D03235
| [1] CSF3R CSF3R 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [1] 60 60 |
340 | Other: Donor Lymphocyte Infusion | - | - | - | - | [1] 65 65 |
341 | Other: Dosage of Delta-aminolevulinic acid and Porphobilinogen | [2] Aminolevulinic acid Aminolevulinic acid, Porphobilinogen | [2] D02908
D02908
,
D07567
| - | - | [1] 254 254 |
342 | Other: Dose reduction to 2mg/L | - | - | - | - | [1] 46 46 |
343 | Other: Dose reduction to 5mg/L | - | - | - | - | [1] 46 46 |
344 | Other: Dried blood spot test for MPS | - | - | - | - | [1] 19 19 |
345 | Other: Drug free | - | - | - | - | [1] 49 49 |
346 | Other: Dual Task Performance | - | - | - | - | [1] 13 13 |
347 | Other: Dummy Tripterygium wilfordii Hook F (TwHF) | [1] Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | [1] 46 46 |
348 | Other: Dynamic Balance Training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
349 | Other: Dynamic balance walking training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
350 | Other: Dystrophin levels | - | - | - | - | [1] 113 113 |
351 | Other: DYT 1 Dystonia | - | - | - | - | [1] 6 6 |
352 | Other: DYT 1 Dystonia (Healthy Control) | - | - | - | - | [1] 6 6 |
353 | Other: e-Monitoring | - | - | - | - | [1] 97 97 |
354 | Other: Eating Assessment Tool 10 | - | - | - | - | [1] 2 2 |
355 | Other: Eating Assessment Tool-10 | - | - | - | - | [1] 2 2 |
356 | Other: Echocardiogram | - | - | - | - | [1] 113 113 |
357 | Other: Eculizumab | [1] Eculizumab Eculizumab | [1] D03940
D03940
| [1] C5 C5 💬 | [10] Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | [1] 109 109 |
358 | Other: EEnG Questionnaire | - | - | - | - | [1] 291 291 |
359 | Other: EIT | - | - | - | - | [1] 228 228 |
360 | Other: Electroencephalogram (EEG) awake andextended overnight | - | - | - | - | [1] 19 19 |
361 | Other: Elektro-Entero-Graphy procedure | - | - | - | - | [1] 291 291 |
362 | Other: Elimination diet | - | - | - | - | [1] 98 98 |
363 | Other: Empiric use of Calcium Carbonate and Calcitriol | [3] Calcitriol Calcitriol, Calcium, Carbonate ion | [1] D00129
D00129
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 235 235 |
364 | Other: Endurance | - | - | - | - | [1] 6 6 |
365 | Other: enteral nutrition | - | - | - | - | [1] 96 96 |
366 | Other: Epiduroscopy | - | - | - | - | [1] 70 70 |
367 | Other: Epistaxis charts | - | - | - | - | [1] 227 227 |
368 | Other: EUS procedure | - | - | - | - | [1] 298 298 |
369 | Other: Evaluation by Investigator | - | - | - | - | [1] 6 6 |
370 | Other: Evaluation of degree chronic fatigue. | - | - | - | - | [1] 13 13 |
371 | Other: Event-related evoked potential using electroencephalography (EEG). | - | - | - | - | [1] 6 6 |
372 | Other: Exclusion Diet | - | - | - | - | [1] 96 96 |
373 | Other: Exclusive enteral nutrition | - | - | - | - | [1] 96 96 |
374 | Other: Exclusive Enteral Nutrition (EEN) | - | - | - | - | [1] 96 96 |
375 | Other: Exercise capacity | - | - | - | - | [1] 299 299 |
376 | Other: Exercise echocardiography | - | - | - | - | [1] 58 58 |
377 | Other: Exercise followed cold water immersion | [1] Water Water | [1] D00001
D00001
| - | - | [1] 46 46 |
378 | Other: Exercise intervention | - | - | - | - | [2] 13 13, 18 |
379 | Other: Exposure to methylprednisolone during pregnancy | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
380 | Other: Extracorporeal Photopheresis (ECP) with Methoxsalen | [1] Methoxsalen Methoxsalen | [1] D00139
D00139
| - | - | [1] 51 51 |
381 | Other: Faecal bacterial transplantation | - | - | - | - | [1] 97 97 |
382 | Other: Fast Mimicking Diet | - | - | - | - | [1] 97 97 |
383 | Other: fatigue | - | - | - | - | [1] 13 13 |
384 | Other: Fear of falling | - | - | - | - | [1] 13 13 |
385 | Other: fingolimod | [1] Fingolimod Fingolimod | [1] D10001
D10001
| [1] S1PR1 S1PR1 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
386 | Other: Fitbit Activity Monitor | [1] Methamidophos Methamidophos | - | - | - | [1] 49 49 |
387 | Other: flow cytometry | - | - | - | - | [3] 28 28, 51, 60 |
388 | Other: Fluid Restriction | - | - | - | - | [1] 72 72 |
389 | Other: Fluorescein angiography | [1] Fluorescein Fluorescein | [2] D01261
D01261
,
D02024
| - | - | [1] 19 19 |
390 | Other: fog | - | - | - | - | [1] 6 6 |
391 | Other: Follow-up study of the untreated cohort | - | - | - | - | [1] 193 193 |
392 | Other: Food Diary | - | - | - | - | [1] 65 65 |
393 | Other: Four Square Step Test | - | - | - | - | [2] 6 6, 13 |
394 | Other: Fractional Exhaled NO (FENO) | - | - | - | - | [1] 96 96 |
395 | Other: Fresh Frozen Plasma | - | - | - | - | [1] 14 14 |
396 | Other: Fruit juice | - | - | - | - | [1] 299 299 |
397 | Other: Functional involvement of identified epigenetic alterations | - | - | - | - | [1] 102 102 |
398 | Other: Functional mobility | - | - | - | - | [2] 6 6, 13 |
399 | Other: Functional Oral Intake Scale | - | - | - | - | [1] 2 2 |
400 | Other: Functional Reach Test | - | - | - | - | [2] 6 6, 13 |
401 | Other: Gadobutrol | [1] Gadobutrol Gadobutrol | [1] D07420
D07420
| - | - | [1] 46 46 |
402 | Other: Gait and balance group training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
403 | Other: General and Neurological examination | - | - | - | - | [1] 19 19 |
404 | Other: general population | - | - | - | - | [2] 46 46, 271 |
405 | Other: Generation of Induced Pluripotent Stem Cells (iPSC) from fibroblasts obtained by skin biopsy | - | - | - | - | [1] 102 102 |
406 | Other: Genetic data/DNA/RNA | - | - | - | - | [3] 49 49, 51, 85 |
407 | Other: GH pause | - | - | - | - | [1] 78 78 |
408 | Other: GHRH plus arginine test | [2] Arginine Arginine, Somatorelin | [2] D02982
D02982
,
D08523
| [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
409 | Other: GHRH+Arg, GHRH+Arg, ITT | [1] Somatorelin Somatorelin | [1] D08523
D08523
| [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
410 | Other: Glucose | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 254 254 |
411 | Other: Glucose -potentiated arginine (GPA) stimulation tests | [2] Arginine Arginine, Dextrose, unspecified form | [1] D02982
D02982
| - | - | [1] 299 299 |
412 | Other: Glucose profile for 2 weeks | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 299 299 |
413 | Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the OGTT and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the IGTT | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 299 299 |
414 | Other: Glycerine gel | [1] Glycerin Glycerin | [1] D00028
D00028
| - | - | [1] 265 265 |
415 | Other: Gold Standard Questionnaire | [1] Gold Gold | - | - | - | [1] 291 291 |
416 | Other: Green tea (Camellia sinensis) | [1] Green tea leaf Green tea leaf | [1] D06903
D06903
| - | - | [1] 96 96 |
417 | Other: Groningen Anti-Inflammatory Diet (GrAID) | - | - | - | - | [1] 96 96 |
418 | Other: Group 2 (DMARDS treated group) | - | - | - | - | [1] 46 46 |
419 | Other: Group B SLE one blood donation | - | - | - | - | [1] 49 49 |
420 | Other: Group balance training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
421 | Other: Group Exercise: community setting | - | - | - | - | [1] 70 70 |
422 | Other: Growth hormone | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
423 | Other: GSK2586184 single dose taken with food | - | - | - | - | [1] 49 49 |
424 | Other: GSK2586184 single dose taken without food | - | - | - | - | [1] 49 49 |
425 | Other: Haematopoietic Stem Cell Transplantation (HSCT) | - | - | - | - | [1] 65 65 |
426 | Other: Hand training | - | - | - | - | [1] 46 46 |
427 | Other: Harkány medicinal water | [1] Water Water | [1] D00001
D00001
| - | - | [1] 46 46 |
428 | Other: healthy controls | - | - | - | - | [1] 63 63 |
429 | Other: Healthy volunteers | - | - | - | - | [1] 46 46 |
430 | Other: hemicellulose crystalline | - | - | - | - | [1] 6 6 |
431 | Other: Hepatic elastography | - | - | - | - | [1] 299 299 |
432 | Other: High energy / protein diet. | - | - | - | - | [1] 96 96 |
433 | Other: High Glycemic Index Meal | - | - | - | - | [1] 299 299 |
434 | Other: High intensity exercise and balance training | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
435 | Other: high performance liquid chromatography | - | - | - | - | [1] 96 96 |
436 | Other: High resolution peripheral quantitative computed tomography (HRpQCT) | - | - | - | - | [1] 172 172 |
437 | Other: High Water Intake | [1] Water Water | [1] D00001
D00001
| - | - | [1] 67 67 |
438 | Other: High-impact exercise intervention | - | - | - | - | [1] 96 96 |
439 | Other: High-intensity training in shallow and deep water | [1] Water Water | [1] D00001
D00001
| - | - | [1] 6 6 |
440 | Other: Histamine | [1] Histamine Histamine | [1] D08040
D08040
| [4] HRH1 HRH1, HRH2, HRH3, HRH4 💬 | [4] Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | [1] 13 13 |
441 | Other: Histone acetylation profiles of cells of SRT patients with CREBBP mutations | - | - | - | - | [1] 102 102 |
442 | Other: Historical control | - | - | - | - | [1] 2 2 |
443 | Other: Hoehn and Yahr Scale | - | - | - | - | [1] 6 6 |
444 | Other: Home functional balance physiotherapy | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
445 | Other: Honey | [1] Honey Honey | [1] D06776
D06776
| - | - | [1] 98 98 |
446 | Other: Human Milk Derived Fortifier | [1] Cow milk Cow milk | - | - | - | [1] 210 210 |
447 | Other: Human umbilical cord-derived MSCs and cyclosporin A | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 60 60 |
448 | Other: Human/Bovine Milk | [1] Cow milk Cow milk | - | - | - | [1] 210 210 |
449 | Other: Hydrocortisone | [1] Hydrocortisone Hydrocortisone (Synonym: Oto End 10) | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 75 75 |
450 | Other: Hydrogen peroxide | [2] Hydrogen Hydrogen, Hydrogen peroxide | [1] D00008
D00008
| - | - | [1] 13 13 |
451 | Other: Hydroxychloroquine/Chloroquine | [2] Chloroquine Chloroquine, Hydroxychloroquine | [4] D02125
D02125
,
D02366
,
D03469
,
D08050
| - | - | [1] 46 46 |
452 | Other: Hyperbaric oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 96 96 |
453 | Other: Hyperbaric Oxygen Therapy | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [2] 97 97, 226 |
454 | Other: Hyperpolarized Xenon MRI | [1] Xenon Xenon | [2] D01901
D01901
,
D06339
| - | - | [1] 299 299 |
455 | Other: Hypoglycemic Clamp | - | - | - | - | [1] 299 299 |
456 | Other: Hypothyroidism QOL questionnaire | - | - | - | - | [1] 80 80 |
457 | Other: Ibuprofen and Isosorbide Dinitrate combination | [2] Ibuprofen Ibuprofen (Synonym: Otis Clapp Ultraprin), Isosorbide dinitrate | [5] D00126
D00126
,
D00516
,
D01122
,
D04490
,
D06606
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 113 113 |
458 | Other: Iloprost (Ventavis inhaled, BAYQ6256) | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
459 | Other: Imaging | - | - | - | - | [1] 13 13 |
460 | Other: Imitation Surgical Procedure (ISP) | - | - | - | - | [1] 6 6 |
461 | Other: immunologic technique | - | - | - | - | [1] 49 49 |
462 | Other: Impact of biotherapy on postoperative morbidity in ulcerative colitis | - | - | - | - | [1] 97 97 |
463 | Other: Impact Peptide 1.5 | - | - | - | - | [1] 299 299 |
464 | Other: inactive drug | - | - | - | - | [1] 226 226 |
465 | Other: Incontinence Severity | - | - | - | - | [1] 13 13 |
466 | Other: Individualized exercises: clinical setting | - | - | - | - | [1] 70 70 |
467 | Other: Induced hypotonic hyponatremia - SIAD model | - | - | - | - | [1] 72 72 |
468 | Other: infliximab (IFX) infusion | [1] Infliximab Infliximab | [1] D02598
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
469 | Other: Inhalable Hypertonic saline 7% | - | - | - | - | [1] 299 299 |
470 | Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1% | [1] Hyaluronic acid Hyaluronic acid | [1] D08043
D08043
| - | - | [1] 299 299 |
471 | Other: Inhaled Hyperpolarized Xenon-129 | [1] Xenon Xenon | [2] D01901
D01901
,
D06339
| - | - | [1] 228 228 |
472 | Other: Intensify treatment with the existing drug | - | - | - | - | [2] 96 96, 97 |
473 | Other: intensive supportive care | - | - | - | - | [1] 66 66 |
474 | Other: Intrathecal saline injection | - | - | - | - | [1] 13 13 |
475 | Other: ISA 51 | - | - | - | - | [1] 50 50 |
476 | Other: ISA 51 VG | - | - | - | - | [1] 49 49 |
477 | Other: ITT, ITT, GHRH+Arg. | [1] Somatorelin Somatorelin | [1] D08523
D08523
| [1] GHRHR GHRHR 💬 | [2] Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
478 | Other: IV saline infusion | - | - | - | - | [1] 96 96 |
479 | Other: IV steroids combination alone | - | - | - | - | [1] 41 41 |
480 | Other: IVIg | [1] Human immunoglobulin G Human immunoglobulin G | - | - | - | [1] 35 35 |
481 | Other: Joint Mobilizations (spine, sacroiliac, hip) | - | - | - | - | [1] 70 70 |
482 | Other: Kesimpta | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
483 | Other: Ketogenic Diet | - | - | - | - | [2] 19 19, 67 |
484 | Other: Lab Work | - | - | - | - | [1] 46 46 |
485 | Other: Laboratory Biomarker Analysis | - | - | - | - | [21] 11 11, 13, 14, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 |
486 | Other: Language Intervention | - | - | - | - | [1] 206 206 |
487 | Other: Lengthening adalimumab dosing interval | [1] Adalimumab Adalimumab | [1] D02597
D02597
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 96 96 |
488 | Other: Leukapheresis- Collection of stem cells | - | - | - | - | [1] 96 96 |
489 | Other: levothyroxine | [1] Levothyroxine Levothyroxine | [2] D01010
D01010
,
D08125
| [2] THRA THRA, THRB 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬 | [1] 78 78 |
490 | Other: Liberation therapy | - | - | - | - | [1] 13 13 |
491 | Other: Liquid Meal Test (Carbohydrate-rich) | - | - | - | - | [1] 299 299 |
492 | Other: Liquid Meal Test (Fat-rich) | - | - | - | - | [1] 299 299 |
493 | Other: Liquid Meal Test (Mixed) | - | - | - | - | [1] 299 299 |
494 | Other: Liver Evaluation | - | - | - | - | [1] 240 240 |
495 | Other: Liver questionnaire | - | - | - | - | [1] 231 231 |
496 | Other: Losartan | [1] Losartan Losartan | [2] D00357
D00357
,
D08146
| [1] AGTR1 AGTR1 💬 | [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
497 | Other: Low Blood Pressure Control | - | - | - | - | [1] 67 67 |
498 | Other: Low dose (1 mcg) ACTH stimulation test | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 193 193 |
499 | Other: Low Glycemic Index Meal | - | - | - | - | [1] 299 299 |
500 | Other: Low n-6 PUFA Diet | - | - | - | - | [1] 96 96 |
501 | Other: Low-intensity exercise therapy | - | - | - | - | [1] 298 298 |
502 | Other: Lower Limb Strength | - | - | - | - | [1] 6 6 |
503 | Other: Magnetic Resonance Imaging (MRI) | - | - | - | - | [1] 113 113 |
504 | Other: Mangafodipir trisodium | [1] Mangafodipir Mangafodipir | [1] D08262
D08262
| - | - | [1] 58 58 |
505 | Other: Meal Challenge | - | - | - | - | [1] 240 240 |
506 | Other: measure of endothelial function | - | - | - | - | [1] 299 299 |
507 | Other: Measurement of drug (Adalimumab/Infliximab) | [2] Adalimumab Adalimumab, Infliximab | [2] D02597
D02597
,
D02598
| [1] TNF TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 96 96, 97 |
508 | Other: Medical air | [2] Medical air Medical air, Oxygen | [1] D00003
D00003
| - | - | [1] 85 85 |
509 | Other: medical chart review | - | - | - | - | [1] 60 60 |
510 | Other: Medical History Questionnaires | - | - | - | - | [1] 65 65 |
511 | Other: Medication Compliance Phone Call | - | - | - | - | [1] 98 98 |
512 | Other: Mesalazine | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
513 | Other: Metabolic Exercise Testing using stationary bicycle | - | - | - | - | [1] 113 113 |
514 | Other: Metformin | [1] Metformin Metformin | [2] D00944
D00944
,
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 46 46 |
515 | Other: Methacholine Challenge Test | [1] Methacholine Methacholine | - | - | - | [1] 96 96 |
516 | Other: Methotrexate therapy | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
517 | Other: MIBG label with I123 or I124 | - | - | - | - | [1] 6 6 |
518 | Other: Microindentation | - | - | - | - | [1] 172 172 |
519 | Other: mitoxantrone - immunomodulator | [1] Mitoxantrone Mitoxantrone | [2] D02166
D02166
,
D08224
| [2] TOP2A TOP2A, TOP2B 💬 | [1] Platinum drug resistance Platinum drug resistance 💬 | [1] 13 13 |
520 | Other: Mixed meal test evaluation test arm | - | - | - | - | [1] 299 299 |
521 | Other: Mixed Meal Tolerance Test | - | - | - | - | [1] 299 299 |
522 | Other: Mobile platform exercise | - | - | - | - | [1] 6 6 |
523 | Other: Mock injection | - | - | - | - | [1] 90 90 |
524 | Other: modified Atkins diet | - | - | - | - | [1] 145 145 |
525 | Other: Modified Mixed Meal Tolerance Test | - | - | - | - | [1] 65 65 |
526 | Other: Modified Oral Glucose Tolerance Test | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 65 65 |
527 | Other: Modified paleolithic diet | - | - | - | - | [1] 13 13 |
528 | Other: Monthly assessments of functional motor abilities by a trained therapist | - | - | - | - | [1] 3 3 |
529 | Other: Motor Assessments before taking regular PD treatment | - | - | - | - | [1] 6 6 |
530 | Other: Motor Assessments on regular PD treatment | - | - | - | - | [1] 6 6 |
531 | Other: MP+DDCI | - | - | - | - | [1] 6 6 |
532 | Other: MP-Equivalent | - | - | - | - | [1] 6 6 |
533 | Other: MP-Low | - | - | - | - | [1] 6 6 |
534 | Other: MPS I | - | - | - | - | [1] 19 19 |
535 | Other: MRI | - | - | - | - | [3] 6 6, 127, 206 |
536 | Other: MSCs | - | - | - | - | [1] 13 13 |
537 | Other: Multidisciplinary intensive rehabilitation treatment | - | - | - | - | [1] 6 6 |
538 | Other: Muscle oxygenation | - | - | - | - | [1] 299 299 |
539 | Other: Music | - | - | - | - | [1] 6 6 |
540 | Other: myBETAapp | - | - | - | - | [1] 13 13 |
541 | Other: N-thymidine | [1] Thymidine Thymidine | - | - | - | [1] 215 215 |
542 | Other: Natalizumab | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
543 | Other: Natalizumab discontinuation | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
544 | Other: natural herbs of coconut, aloe vera, and pepperint | [2] Aloe vera leaf Aloe vera leaf (Synonym: C Ottways Lax Tab), Coconut | - | - | - | [1] 53 53 |
545 | Other: NBT-NM108 (0 g/day) | - | - | - | - | [1] 13 13 |
546 | Other: Neupro 4 mg / 24 Hr. Transdermal Patch | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
547 | Other: Neurology exam | - | - | - | - | [1] 19 19 |
548 | Other: Neuromuscular evaluation | - | - | - | - | [1] 13 13 |
549 | Other: Nil per os | - | - | - | - | [1] 291 291 |
550 | Other: Nintendo Wii Fit Balance exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
551 | Other: No active treatment | - | - | - | - | [1] 274 274 |
552 | Other: No anti-inflammatory treatment | - | - | - | - | [1] 271 271 |
553 | Other: No device | - | - | - | - | [1] 13 13 |
554 | Other: No doxycycline | [1] Doxycycline Doxycycline | [5] D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | [1] 299 299 |
555 | Other: No enzyme therapy | - | - | - | - | [1] 298 298 |
556 | Other: NO intervention | - | - | - | - | [4] 13 13, 70, 96, 97 |
557 | Other: No Intervention: Standard of Care | - | - | - | - | [1] 85 85 |
558 | Other: No IT treatment | - | - | - | - | [1] 19 19 |
559 | Other: No MSDMDs therapy (control) | - | - | - | - | [1] 13 13 |
560 | Other: No pancreatic enzyme replacement therapy | - | - | - | - | [1] 299 299 |
561 | Other: No Plasma Exchange | - | - | - | - | [2] 43 43, 44 |
562 | Other: No treatment | - | - | - | - | [2] 53 53, 274 |
563 | Other: No Treatment Arm | - | - | - | - | [1] 13 13 |
564 | Other: No treatment given | - | - | - | - | [1] 78 78 |
565 | Other: Non Impact Aerobics | - | - | - | - | [1] 13 13 |
566 | Other: Non-hormonal period | - | - | - | - | [1] 299 299 |
567 | Other: Non-Motor Symptoms | - | - | - | - | [1] 6 6 |
568 | Other: Noninvasive actigraphy monitor | [1] Methamidophos Methamidophos | - | - | - | [1] 86 86 |
569 | Other: Nordic walking (only osteoporosis group) | - | - | - | - | [1] 6 6 |
570 | Other: Normal (control) diet | - | - | - | - | [1] 240 240 |
571 | Other: normal diet | - | - | - | - | [1] 96 96 |
572 | Other: normal saline | - | - | - | - | [4] 13 13, 222, 226, 280 |
573 | Other: Normal Saline for injection | - | - | - | - | [1] 84 84 |
574 | Other: NS | - | - | - | - | [1] 96 96 |
575 | Other: Numerical rating scale | - | - | - | - | [1] 46 46 |
576 | Other: Nutrition counseling | - | - | - | - | [1] 298 298 |
577 | Other: Obese | - | - | - | - | [1] 75 75 |
578 | Other: Observation | - | - | - | - | [1] 265 265 |
579 | Other: Observation of Ocrelizumab as Treatment in RRMS Patients | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
580 | Other: Observation Only | - | - | - | - | [1] 331 331 |
581 | Other: Observational | - | - | - | - | [1] 90 90 |
582 | Other: Observational cohort | - | - | - | - | [1] 6 6 |
583 | Other: Observational Control | - | - | - | - | [1] 13 13 |
584 | Other: Ocrelizumab | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
585 | Other: Ofatumumab | [1] Ofatumumab Ofatumumab | [1] D09314
D09314
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
586 | Other: OGTT | - | - | - | - | [1] 299 299 |
587 | Other: On-demand treatment | - | - | - | - | [1] 299 299 |
588 | Other: One-leg Stance Test | - | - | - | - | [1] 13 13 |
589 | Other: Ophthalmologic examinations | - | - | - | - | [1] 299 299 |
590 | Other: Optimized Supportive Care | - | - | - | - | [1] 66 66 |
591 | Other: Optimizing basal infusion (B.I) | - | - | - | - | [1] 70 70 |
592 | Other: Optional Blood-Oxygen-level Dependent functionalMRI | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 6 6 |
593 | Other: Oral Glucose tolerance test | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [3] 160 160, 195, 299 |
594 | Other: Oral Glucose Tolerance Test (OGTT) assessment arm | [1] Dextrose, unspecified form Dextrose, unspecified form | - | - | - | [1] 299 299 |
595 | Other: Oral Nitric Oxide testing | [1] Nitric Oxide Nitric Oxide | [1] D00074
D00074
| - | - | [1] 98 98 |
596 | Other: Other Biologic Agents | - | - | - | - | [2] 96 96, 97 |
597 | Other: Other biological samples to biobank (skin, lung and muscle biopsies | - | - | - | - | [3] 49 49, 51, 85 |
598 | Other: Other intervention(s) | - | - | - | - | [1] 70 70 |
599 | Other: Other: Disease modifying therapies (DMT) | - | - | - | - | [1] 13 13 |
600 | Other: Other: Symptomatic treatment of ALS | - | - | - | - | [1] 2 2 |
601 | Other: Outpatient rheumatology department | - | - | - | - | [1] 46 46 |
602 | Other: Overnight metyrapone test | [1] Metyrapone Metyrapone | [2] D00410
D00410
,
D05019
| [1] CYP11B1 CYP11B1 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | [1] 193 193 |
603 | Other: Oxygen | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 85 85 |
604 | Other: Oxygen (2Liter/min) | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 85 85 |
605 | Other: Oxygen (4Liter/min) | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 85 85 |
606 | Other: Oxygen - Air | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 299 299 |
607 | Other: Oxygen Supplementation | [1] Oxygen Oxygen | [1] D00003
D00003
| - | - | [1] 86 86 |
608 | Other: ozone therapy | [1] Ozone Ozone | - | - | - | [1] 51 51 |
609 | Other: Packing | - | - | - | - | [1] 227 227 |
610 | Other: pain | - | - | - | - | [1] 13 13 |
611 | Other: Palliative Care | - | - | - | - | [5] 19 19, 65, 120, 160, 326 |
612 | Other: Parkinson mPower mobile application | - | - | - | - | [1] 6 6 |
613 | Other: Parts A/B: Sham Control | - | - | - | - | [1] 19 19 |
614 | Other: Passive : lecture series | - | - | - | - | [1] 13 13 |
615 | Other: PBO | - | - | - | - | [1] 162 162 |
616 | Other: PCDAI | - | - | - | - | [1] 96 96 |
617 | Other: PD exercise intervention | - | - | - | - | [1] 6 6 |
618 | Other: PD vitamin + exercise | - | - | - | - | [1] 6 6 |
619 | Other: PEAK | - | - | - | - | [1] 13 13 |
620 | Other: Peanut Butter | [1] Peanut Peanut | - | - | - | [1] 13 13 |
621 | Other: Pentadecanoic acid (PA) and Triheptadecanoin (THA) | - | - | - | - | [1] 299 299 |
622 | Other: PENTASA (mesalamine/ 5-Aminosalicylic acid (5-ASA) | [2] Aminosalicylic acid Aminosalicylic acid, Mesalazine | [2] D00162
D00162
,
D00377
| - | - | [1] 97 97 |
623 | Other: Periodized exercise training | - | - | - | - | [1] 13 13 |
624 | Other: Peripheral Blood Stem Cells | - | - | - | - | [2] 60 60, 62 |
625 | Other: Pharmacogenomic Study | - | - | - | - | [1] 26 26 |
626 | Other: Pharmacokinetic analysis | - | - | - | - | [1] 49 49 |
627 | Other: Pharmacological Study | - | - | - | - | [7] 28 28, 34, 62, 74, 89, 232, 331 |
628 | Other: Phenylalanine (Phe)-restricted diet | [1] Phenylalanine Phenylalanine | [1] D00021
D00021
| - | - | [1] 240 240 |
629 | Other: Physalis angulata ethanol extract | [1] Ethanol Ethanol (Synonym: hand sanitizer OTC) | [4] D00068
D00068
,
D02798
,
D04855
,
D06542
| - | - | [1] 51 51 |
630 | Other: Physical Function Performance Test | - | - | - | - | [1] 6 6 |
631 | Other: Physical Therapy | - | - | - | - | [2] 6 6, 70 |
632 | Other: Pittsburgh Compound B [11C]-PIB | [1] Pittsburgh Compound B Pittsburgh Compound B | - | - | - | [1] 6 6 |
633 | Other: Plant-based diet | - | - | - | - | [1] 46 46 |
634 | Other: plasticity-based computerized cognitive remediation program | - | - | - | - | [1] 13 13 |
635 | Other: PNF | - | - | - | - | [1] 13 13 |
636 | Other: Position Sense | - | - | - | - | [1] 13 13 |
637 | Other: Postoperative nausea and vomiting at 24 hour | - | - | - | - | [1] 235 235 |
638 | Other: Postoperative nausea and vomiting at 6 hour | - | - | - | - | [1] 235 235 |
639 | Other: Postoperative pain at 24 hour | - | - | - | - | [1] 235 235 |
640 | Other: Postoperative pain at 6 hour | - | - | - | - | [1] 235 235 |
641 | Other: Postoperative sore throat and hoarseness at 24 hour | - | - | - | - | [1] 235 235 |
642 | Other: Postoperative sore throat and hoarseness at 6 hour | - | - | - | - | [1] 235 235 |
643 | Other: Potable water | [1] Water Water | [1] D00001
D00001
| - | - | [1] 19 19 |
644 | Other: prednisone | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
645 | Other: pretreatment antibiotics | - | - | - | - | [1] 97 97 |
646 | Other: Progressive exercise | - | - | - | - | [1] 13 13 |
647 | Other: propensity score | - | - | - | - | [1] 13 13 |
648 | Other: Prospective observational registry | - | - | - | - | [1] 3 3 |
649 | Other: PSP | - | - | - | - | [1] 13 13 |
650 | Other: PTH based Calcium Carbonate and Calcitriol repletion | [4] Calcitriol Calcitriol, Calcium, Calcium carbonate (Synonym: Relief OTC antacid), Carbonate ion | [3] D00129
D00129
,
D00932
,
D10802
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 235 235 |
651 | Other: Pulmonary Function Testing (PFT) | - | - | - | - | [1] 113 113 |
652 | Other: Pulmonary rehabilitation program | - | - | - | - | [1] 85 85 |
653 | Other: QALCIMUM questionnaire | - | - | - | - | [2] 13 13, 46 |
654 | Other: Quality of life assessment | - | - | - | - | [1] 122 122 |
655 | Other: Quality of Life questionnaire | - | - | - | - | [1] 19 19 |
656 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 283, 286, 298 |
657 | Other: quercetin | [1] Quercetin Quercetin | - | - | - | [1] 299 299 |
658 | Other: Questionnaire Administration | - | - | - | - | [4] 16 16, 34, 51, 298 |
659 | Other: Questionnaires | - | - | - | - | [5] 6 6, 13, 41, 93, 96 |
660 | Other: Reaction Time and Postural Control | - | - | - | - | [1] 299 299 |
661 | Other: Real-time data capture app | [1] Bifenthrin Bifenthrin | - | - | - | [1] 46 46 |
662 | Other: Recommendation with regard to nutrition | - | - | - | - | [1] 6 6 |
663 | Other: Reduction group 1 | - | - | - | - | [1] 46 46 |
664 | Other: Reduction group 2 | - | - | - | - | [1] 46 46 |
665 | Other: Refered to general practice | - | - | - | - | [1] 46 46 |
666 | Other: Resistance Exercise Program | - | - | - | - | [1] 46 46 |
667 | Other: Review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry. | [1] Melatonin Melatonin | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 149 149 |
668 | Other: Rheumatoid Arthritis Impact of Disease questionnaire | - | - | - | - | [1] 46 46 |
669 | Other: Rhythmic Auditory Stimulation (RAS) | - | - | - | - | [2] 6 6, 13 |
670 | Other: Rhythmic Balance-Movement Training (rBMT) | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
671 | Other: RMST | - | - | - | - | [1] 256 256 |
672 | Other: Rosemary essential oil | [1] Rosemary Rosemary | - | - | - | [1] 51 51 |
673 | Other: Rotigotine | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
674 | Other: Routine | - | - | - | - | [1] 240 240 |
675 | Other: routine management | - | - | - | - | [1] 291 291 |
676 | Other: routine therapy | - | - | - | - | [1] 299 299 |
677 | Other: RP% Measurement by FCM as a Diagnostic Test for ITP | - | - | - | - | [1] 63 63 |
678 | Other: Salbutamol nebulisation and with CPAP | [1] Salbutamol Salbutamol | [1] D02147
D02147
| [1] ADRB2 ADRB2 💬 | [9] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 228 228 |
679 | Other: Saline | - | - | - | - | [8] 2 2, 6, 46, 97, 98, 256, 274, 301 |
680 | Other: Saline as a nasal spray | - | - | - | - | [1] 226 226 |
681 | Other: Saline solution | - | - | - | - | [1] 67 67 |
682 | Other: Saline solution. | - | - | - | - | [1] 67 67 |
683 | Other: Screening to prevent falls | - | - | - | - | [1] 6 6 |
684 | Other: secukinumab | [1] Secukinumab Secukinumab | [1] D09967
D09967
| [1] IL17A IL17A 💬 | [6] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬 | [1] 271 271 |
685 | Other: Serum calcium concentrations results | [1] Calcium Calcium | - | - | - | [1] 235 235 |
686 | Other: serum levels of angiogenin, bFGF, VEGF | [1] Basic Fibroblast Growth Factor Basic Fibroblast Growth Factor | - | - | - | [1] 56 56 |
687 | Other: Sham | - | - | - | - | [1] 301 301 |
688 | Other: Sham (no implant) | - | - | - | - | [1] 90 90 |
689 | Other: Sham abdominal compression | - | - | - | - | [1] 17 17 |
690 | Other: Sham Comparator | - | - | - | - | [1] 299 299 |
691 | Other: Sham group | - | - | - | - | [1] 6 6 |
692 | Other: Sham procedure | - | - | - | - | [1] 90 90 |
693 | Other: Sham Surgery | - | - | - | - | [1] 6 6 |
694 | Other: Sham-procedure | - | - | - | - | [2] 90 90, 303 |
695 | Other: Sham-procedure (dose cohort 1&2 only) | - | - | - | - | [2] 90 90, 303 |
696 | Other: Simvastatin | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 46 46 |
697 | Other: Siponimod | [1] Siponimod Siponimod | [1] D11460
D11460
| [2] S1PR1 S1PR1, S1PR5 💬 | [3] FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | [1] 13 13 |
698 | Other: SLE treatment | - | - | - | - | [1] 49 49 |
699 | Other: Smartphone Application | - | - | - | - | [1] 49 49 |
700 | Other: Smartphone-based balance exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
701 | Other: sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] D02056
D02056
| - | - | [1] 51 51 |
702 | Other: Specific SL-therapy | - | - | - | - | [1] 6 6 |
703 | Other: specifically design 6 month resistance training program | - | - | - | - | [1] 13 13 |
704 | Other: Specimen Collection | - | - | - | - | [1] 215 215 |
705 | Other: Spinning grp | - | - | - | - | [1] 13 13 |
706 | Other: Sputum Sample | - | - | - | - | [1] 299 299 |
707 | Other: Squat-to-stand maneuver | - | - | - | - | [1] 58 58 |
708 | Other: Standard | - | - | - | - | [1] 67 67 |
709 | Other: Standard Blood Pressure Control | - | - | - | - | [1] 67 67 |
710 | Other: Standard care | - | - | - | - | [1] 227 227 |
711 | Other: standard immune suppression, oral | - | - | - | - | [1] 228 228 |
712 | Other: Standard nutrition | - | - | - | - | [1] 96 96 |
713 | Other: standard of care | - | - | - | - | [7] 13 13, 49, 64, 85, 96, 245, 246 |
714 | Other: Standard of care (SOC) | - | - | - | - | [1] 62 62 |
715 | Other: Standard of Care Sildenafil | [1] Sildenafil Sildenafil | [2] D02229
D02229
,
D08514
| [1] PDE5A PDE5A 💬 | [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 90 90, 301 |
716 | Other: Standard steroid treatment | - | - | - | - | [1] 113 113 |
717 | Other: Standard therapy | - | - | - | - | [1] 49 49 |
718 | Other: Standard Treatment | - | - | - | - | [1] 227 227 |
719 | Other: Standard treatment according to the Clinical protocols | - | - | - | - | [3] 49 49, 51, 235 |
720 | Other: Standard-of-care | - | - | - | - | [1] 86 86 |
721 | Other: Standardized meals | - | - | - | - | [1] 86 86 |
722 | Other: Standardized scales: MDS-UPDRS (Part II to IV) and RDRS | - | - | - | - | [1] 6 6 |
723 | Other: Static Balance Test | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
724 | Other: Stem Cell Transplant | - | - | - | - | [1] 96 96 |
725 | Other: Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [1] 231 231 |
726 | Other: sterile saline | - | - | - | - | [1] 46 46 |
727 | Other: Stool Sample | - | - | - | - | [2] 6 6, 299 |
728 | Other: Strength training | - | - | - | - | [1] 13 13 |
729 | Other: Strength training in shallow water and dry land | [1] Water Water | [1] D00001
D00001
| - | - | [1] 6 6 |
730 | Other: Subacute hypoxic exposures | - | - | - | - | [1] 86 86 |
731 | Other: Subconjunctival injection of saline | - | - | - | - | [1] 90 90 |
732 | Other: Subcortical Stimulation | - | - | - | - | [1] 6 6 |
733 | Other: Sugar pill | - | - | - | - | [1] 90 90 |
734 | Other: Sulfur Pool & Medicinal Mud | - | - | - | - | [1] 46 46 |
735 | Other: Supervised physical therapy | - | - | - | - | [1] 13 13 |
736 | Other: Surgery | - | - | - | - | [2] 74 74, 96 |
737 | Other: Swallowing Quality of Life Questionnaire | - | - | - | - | [1] 2 2 |
738 | Other: Swallowing Related Quality of Life Questionnaire | - | - | - | - | [1] 2 2 |
739 | Other: Symptom Survey | - | - | - | - | [1] 98 98 |
740 | Other: Symptomatic hypocalcaemia at 24 hour | - | - | - | - | [1] 235 235 |
741 | Other: Symptomatic hypocalcaemia at 6 hour | - | - | - | - | [1] 235 235 |
742 | Other: Symptomatic therapy | - | - | - | - | [1] 160 160 |
743 | Other: t-DCS group | - | - | - | - | [1] 6 6 |
744 | Other: Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy Scale | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
745 | Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA | [2] Indium Indium, Pentetic acid | [1] D05422
D05422
| - | - | [1] 299 299 |
746 | Other: Telerehabilitation Based Functional Balance and Mobility Exercise | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 6 6 |
747 | Other: Telerehabilitation Based LSVT BIG Exercise Protocol | - | - | - | - | [1] 6 6 |
748 | Other: Test Soda | - | - | - | - | [1] 299 299 |
749 | Other: The Center for Neurologic Studies Bulbar Function Scale | - | - | - | - | [1] 2 2 |
750 | Other: The Center for Neurologic Study Bulbar Function Scale | - | - | - | - | [1] 2 2 |
751 | Other: The patients' parents have to complete the VINELAND II adaptive behavior scales scoring, The Sleep Disturbance Scale for Children (SDSC) and Horne & Ostberg Circadian Typology Questionnaire | - | - | - | - | [1] 149 149 |
752 | Other: the timed 360° turn test | - | - | - | - | [1] 6 6 |
753 | Other: Therapy Education | - | - | - | - | [1] 97 97 |
754 | Other: Threonine | [1] Threonine Threonine | [1] D00041
D00041
| - | - | [2] 96 96, 97 |
755 | Other: Timed Up an Go Test | - | - | - | - | [1] 13 13 |
756 | Other: Timed Up and Go Test | - | - | - | - | [1] 6 6 |
757 | Other: Tobacco questionnaire | [1] Tobacco leaf Tobacco leaf | - | - | - | [1] 299 299 |
758 | Other: Tobramycin time of administration | [1] Tobramycin Tobramycin | [2] D00063
D00063
,
D02542
| - | - | [1] 299 299 |
759 | Other: Training groupe | - | - | - | - | [1] 13 13 |
760 | Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings. | - | - | - | - | [1] 215 215 |
761 | Other: triangular test | - | - | - | - | [1] 96 96 |
762 | Other: Trunk impairment | - | - | - | - | [1] 13 13 |
763 | Other: Trunk Impairment Scale | - | - | - | - | [1] 6 6 |
764 | Other: Trunk position sense | - | - | - | - | [1] 13 13 |
765 | Other: tyramine | [1] Tyramine Tyramine | - | - | - | [1] 6 6 |
766 | Other: UC-MSCs by peripheral intravenous infusion | [1] Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | [1] 96 96 |
767 | Other: Ulcerative Colitis Diet | - | - | - | - | [1] 97 97 |
768 | Other: Ultrasonography assessment | - | - | - | - | [1] 49 49 |
769 | Other: Unified Parkinson's Disease Rating Scale | - | - | - | - | [1] 6 6 |
770 | Other: Untreated Cohort | - | - | - | - | [1] 85 85 |
771 | Other: Untreated contemporaneous cohort | - | - | - | - | [1] 118 118 |
772 | Other: Urine Collection | - | - | - | - | [1] 215 215 |
773 | Other: Use of a postpartum diary and additional blood draws | - | - | - | - | [1] 288 288 |
774 | Other: Use of a postpartum diary and additional blood draws. | - | - | - | - | [1] 288 288 |
775 | Other: USPIO MRI - Gadolinium MRI | [1] Gadolinium Gadolinium | - | - | - | [1] 13 13 |
776 | Other: Usual care | - | - | - | - | [3] 46 46, 107, 299 |
777 | Other: Usual care arm exercise | - | - | - | - | [1] 6 6 |
778 | Other: Usual drug treatment of Parkinson's disease | - | - | - | - | [1] 6 6 |
779 | Other: Valsalva | - | - | - | - | [1] 58 58 |
780 | Other: Vegan Diet | - | - | - | - | [1] 46 46 |
781 | Other: Vegetable Oil | - | - | - | - | [1] 257 257 |
782 | Other: Vehicle | - | - | - | - | [1] 160 160 |
783 | Other: Vehicle (D5W or saline) | - | - | - | - | [1] 66 66 |
784 | Other: Vestibular habituation exercises | - | - | - | - | [1] 13 13 |
785 | Other: Vestibular rehabilitation: balance and eye movement exercises | [1] Isoxaflutole Isoxaflutole | - | - | - | [1] 13 13 |
786 | Other: Virtual reality group | - | - | - | - | [1] 13 13 |
787 | Other: Visual Acuity (VA) | - | - | - | - | [2] 90 90, 301 |
788 | Other: Vital signs | - | - | - | - | [1] 19 19 |
789 | Other: Vitamin K | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [1] 13 13 |
790 | Other: Vitamin K Cream | [1] Phylloquinone Phylloquinone | [1] D00148
D00148
| - | - | [1] 13 13 |
791 | Other: Voluntary cough test | - | - | - | - | [1] 6 6 |
792 | Other: Walk distance test | - | - | - | - | [1] 58 58 |
793 | Other: Water | [1] Water Water | [1] D00001
D00001
| - | - | [1] 67 67 |
794 | Other: Water prescription | [1] Water Water | [1] D00001
D00001
| - | - | [1] 67 67 |
795 | Other: Wheat flour | [1] Wheat Wheat | [1] D06902
D06902
| - | - | [1] 266 266 |
796 | Other: Withdrawal from alpha1 antitrypsin replacement therapy | - | - | - | - | [1] 231 231 |
797 | Other: Withdrawal of dalfampridine-ER 10mg | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
798 | Other: Xanthan Gum | [1] Xanthan gum Xanthan gum | [1] D06333
D06333
| - | - | [1] 98 98 |
799 | OTILIMAB | [1] Otilimab Otilimab | [1] D11343
D11343
(Name: Otilimab) | [1] CSF2 CSF2 💬 | [16] Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [2] 46 46, 256 |
800 | Otilimab (GSK3196165) | [1] Otilimab Otilimab | [1] D11343
D11343
(Name: Otilimab) | [1] CSF2 CSF2 💬 | [16] Acute myeloid leukemia Acute myeloid leukemia, Amoebiasis, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, IL-17 signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Shigellosis, T cell receptor signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | [1] 46 46 |
801 | OTL-101 | - | - | - | - | [1] 65 65 |
802 | OTL-103 | - | - | - | - | [1] 65 65 |
803 | OTL-103 Dispersion for Infusion | - | - | - | - | [1] 65 65 |
804 | OTL-200 | - | - | - | - | [1] 19 19 |
805 | OTL-200 Dispersion for Infusion | - | - | - | - | [1] 19 19 |
806 | OTL38 | - | - | - | - | [1] 46 46 |
807 | Phase 1: Methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
808 | PN 200 tablets (500 mg naproxen and 20 mg omeprazole) (Synonym: Prilosec OTC (TN)) | [2] Naproxen Naproxen, Omeprazole (Synonym: Prilosec OTC) | [5] D00118
D00118
,
D00455
,
D01207
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 46 46, 271 |
809 | PO ciprofloxacin (Synonym: CIPROFLOXACIN OTIC) | [1] Ciprofloxacin Ciprofloxacin (Synonym: Otovel) | [2] D00186
D00186
(Name: Otiprio (TN)),
D02216
(Name: CIPROFLOXACIN OTIC) | - | - | [1] 299 299 |
810 | Response to anakinra associated with methotrexate (Synonym: Otrexup (TN)) | [2] Anakinra Anakinra, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02934
| [4] DHFR DHFR, DHFR2, IL1R1, IL1R2 💬 | [20] Amoebiasis Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [1] 46 46 |
811 | Response to infliximab associated with methotrexate (Synonym: Otrexup (TN)) | [2] Infliximab Infliximab, Methotrexate (Synonym: Otrexup) | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02598
| [3] DHFR DHFR, DHFR2, TNF 💬 | [71] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 46 46 |
812 | Rifaximin+omeprazole+miralax (Synonym: Prilosec OTC (TN)) | [2] Omeprazole Omeprazole (Synonym: Prilosec OTC), Rifaximin | [5] D00455
D00455
,
D01207
,
D02554
,
D05259
(Name: Prilosec OTC (TN)),
D05261
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [1] 96 96 |
813 | Sedatives/Hypnotics,Other | - | - | - | - | [1] 107 107 |
814 | See D.3.9.3 'Other descriptive name' below | - | - | - | - | [1] 46 46 |
815 | Stable weekly dose of methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
816 | Tacrolimus with Methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tacrolimus | [4] D00107
D00107
,
D00142
(Name: Otrexup (TN)),
D02115
,
D08556
| [7] DHFR DHFR, DHFR2, PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [38] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Antifolate resistance, Axon guidance, B cell receptor signaling pathway, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Folate biosynthesis, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, One carbon pool by folate, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 46 46 |
817 | TAK-715 and methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), TAK-715 | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
818 | TAK-783 and methotrexate (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |
819 | Tasocitinib plus Methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tofacitinib | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D09970
| [6] DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | [42] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
820 | TNF-alpha antagonist and other biotherapy | - | - | - | - | [1] 46 46 |
821 | Tocilizumab + methotrexate(MTX) (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tocilizumab | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02596
| [3] DHFR DHFR, DHFR2, IL6R 💬 | [17] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
822 | Tocilizumab plus methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tocilizumab | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02596
| [3] DHFR DHFR, DHFR2, IL6R 💬 | [17] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
823 | Tocilizumab+Methotrexate(MTX) (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tocilizumab | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D02596
| [3] DHFR DHFR, DHFR2, IL6R 💬 | [17] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 46 46 |
824 | Tofacitinib with methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tofacitinib | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D09970
| [6] DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | [42] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
825 | Tofacitinib without methotrexate (Synonym: Otrexup (TN)) | [2] Methotrexate Methotrexate (Synonym: Otrexup), Tofacitinib | [3] D00142
D00142
(Name: Otrexup (TN)),
D02115
,
D09970
| [6] DHFR DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬 | [42] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
826 | Treatment with systemic therapy (methotrexate) (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 162 162 |
827 | Urine samples taken to measure methotrexate and its major metabolite 7-OH-methotrexate level (Synonym: Otrexup (TN)) | [1] Methotrexate Methotrexate (Synonym: Otrexup) | [2] D00142
D00142
(Name: Otrexup (TN)),
D02115
| [2] DHFR DHFR, DHFR2 💬 | [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 46 46 |